Portugal In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2018

Portugal In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2018

Summary

Global Markets Direct’s new report, “Portugal In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2018” provides key market data on the Portugal In Vitro Diagnostics market. The report provides value (USD) million data for each segment and sub-segment within seven market categories – Immuno Chemistry, Clinical Chemistry, Haematology, Infectious Immunology, Microbiology Culture, Histology And Cytology and Genetic Testing. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on company financials and pipeline products, wherever available.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Global Markets Direct’s team of industry experts.

Scope

- Market size and company share data for In Vitro Diagnostics market categories – Immuno Chemistry, Clinical Chemistry, Haematology, Infectious Immunology, Microbiology Culture, Histology And Cytology and Genetic Testing.
- Annualized market revenues (USD million) data for each of the segments and sub-segments within seven market categories. Data from 2004 to 2011, forecast forward for 7 years to 2018.
- 2011 company shares and distribution shares data for each of the twelve market categories.
- Global corporate-level profiles of key companies operating within the Portugal In Vitro Diagnostics market.
- Key players covered include F. Hoffmann-La Roche Ltd., Siemens Healthcare, Abbott Laboratories, bioMerieux S.A., Ortho-Clinical Diagnostics Inc., Beckman Coulter, Inc. and others.

Reasons to buy

- Develop business strategies by identifying the key market categories and segments poised for strong growth.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the Portugal In Vitro Diagnostics competitive landscape.
- Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future.
- What are the key distribution channels and what’s the most preferred mode of product distribution – Identify, understand and capitalize.

1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 6
1.2 List of Figures 8
2 Introduction 10
2.1 What is This Report About? 10
3 In Vitro Diagnostics In Portugal 11
3.1 In Vitro Diagnostics, Portugal, Overall Revenue ($m), USD Constant, 2004-2018 11
3.2 In Vitro Diagnostics, Portugal, Company Share (2010-2011) 17
4 Clinical Chemistry In Portugal 19
4.1 Clinical Chemistry Overall Revenue, (2004-2018) 19
4.1.1 Clinical Chemisty Analyzers, Revenue (2004-2018) 23
4.1.2 Urine Analysis, Revenue (2004-2018) 27
4.2 Clinical Chemistry Distribution Share (2010-2011) 31
4.3 Clinical Chemistry, Portugal, Company Share (2010-2011) 32
5 Genetic Testing In Portugal 34
5.1 Genetic Testing Overall Revenue, (2004-2018) 34
5.2 Genetic Testing Distribution Share (2010-2011) 38
5.3 Genetic Testing, Portugal, Company Share (2010-2011) 39
6 Haematology In Portugal 41
6.1 Haematology Overall Revenue, (2004-2018) 41
6.1.1 Haematology Reagents, Revenue (2004-2018) 45
6.1.2 Immunohaematology, Revenue (2004-2018) 49
6.1.3 Haemostasis, Revenue (2004-2018) 53
6.1.4 Haematology Rapid Tests, Revenue (2004-2018) 57
6.1.5 Haematology Cell Counters, Revenue (2004-2018) 61
6.2 Haematology Distribution Share (2010-2011) 65
6.3 Haematology, Portugal, Company Share (2010-2011) 66
7 Histology And Cytology In Portugal 68
7.1 Histology And Cytology Overall Revenue, (2004-2018) 68
7.2 Histology And Cytology Distribution Share (2010-2011) 72
7.3 Histology And Cytology, Portugal, Company Share (2010-2011) 73
8 Immuno Chemistry In Portugal 75
8.1 Immuno Chemistry Overall Revenue, (2004-2018) 75
8.1.1 Disease Specific Immunochemistry, Revenue (2004-2018) 79
8.1.2 Drugs of Abuse / Toxicology, Revenue (2004-2018) 83
8.1.3 Endocrinology Tests, Revenue (2004-2018) 86
8.1.4 Immunochemistry Rapid Tests, Revenue (2004-2018) 90
8.1.5 Therapeutic Drug Monitoring, Revenue (2004-2018) 94
8.1.6 Immunochemistry Analyzers, Revenue (2004-2018) 98
8.2 Immuno Chemistry Distribution Share (2010-2011) 102
8.3 Immuno Chemistry, Portugal, Company Share (2010-2011) 103
9 Infectious Immunology In Portugal 105
9.1 Infectious Immunology Overall Revenue, (2004-2018) 105
9.1.1 Infectious Immunology Rapid Tests, Revenue (2004-2018) 109
9.2 Infectious Immunology Distribution Share (2010-2011) 113
9.3 Infectious Immunology, Portugal, Company Share (2010-2011) 114
10 Microbiology Culture In Portugal 116
10.1 Microbiology Culture Overall Revenue, (2004-2018) 116
10.1.1 Microbiology Analyzers, Revenue (2004-2018) 120
10.2 Microbiology Culture Distribution Share (2010-2011) 124
10.3 Microbiology Culture, Portugal, Company Share (2010-2011) 125
11 Overview of Key Companies in Portugal In Vitro Diagnostics Market 127
11.1 F. Hoffmann-La Roche Ltd. 127
11.1.1 Company Overview 127
11.2 Siemens Healthcare 127
11.2.1 Company Overview 127
11.3 Abbott Laboratories 128
11.3.1 Company Overview 128
11.4 bioMerieux S.A. 128
11.4.1 Company Overview 128
11.5 Ortho-Clinical Diagnostics Inc. 129
11.5.1 Company Overview 129
11.6 Beckman Coulter, Inc. 129
11.6.1 Company Overview 129
11.7 Bio-Rad Laboratories, Inc. 129
11.7.1 Company Overview 129
11.8 Becton, Dickinson and Company 130
11.8.1 Company Overview 130
11.9 Alere Inc. 130
11.9.1 Company Overview 130
11.10 Sysmex Corporation 131
11.10.1 Company Overview 131
11.11 Danaher Corporation 131
11.11.1 Company Overview 131
11.12 DiaSorin S.p.A 132
11.12.1 Company Overview 132
11.13 Qiagen N.V. 132
11.13.1 Company Overview 132
11.14 Diagnostica Stago, Inc. 133
11.14.1 Company Overview 133
11.15 PerkinElmer, Inc. 133
11.15.1 Company Overview 133
11.16 Thermo Fisher Scientific Inc. 134
11.16.1 Company Overview 134
11.17 Horiba, Ltd. 134
11.17.1 Company Overview 134
11.18 Gen-Probe Incorporated 135
11.18.1 Company Overview 135
11.19 Immucor, Inc. 135
11.19.1 Company Overview 135
11.20 Life Technologies Corporation 136
11.20.1 Company Overview 136
11.21 Cellestis Limited 136
11.21.1 Company Overview 136
11.22 Phadia AB 137
11.22.1 Company Overview 137
12 Appendix 138
12.1 Global Markets Direct Research Methodology 138
12.2 Definitions of Markets Covered in the Report 139
12.2.1 In Vitro Diagnostics 139
12.3 Secondary Research 150
12.4 Primary Research 150
12.5 Models 151
12.6 Forecasts 151
12.7 Expert Panel Validation 151
12.8 Currency Conversion 152
12.9 Contact Us 152
12.10 Disclaimer 152

1.1 List of Tables
Table 1: In Vitro Diagnostics, Portugal, Overall Revenue ($m), USD Constant, 2004-2018 12
Table 2: In Vitro Diagnostics, Portugal, Overall Revenue ($m), USD Constant, Historic, 2004-2011 14
Table 3: In Vitro Diagnostics, Portugal, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 16
Table 4: In Vitro Diagnostics, Portugal, Company Share by Revenue ($m), USD Constant, 2010-2011 18
Table 5: Clinical Chemistry, Portugal, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011 20
Table 6: Clinical Chemistry, Portugal, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018 22
Table 7: Clinical Chemisty Analyzers, Portugal, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 24
Table 8: Clinical Chemisty Analyzers, Portugal, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 26
Table 9: Urine Analysis, Portugal, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 28
Table 10: Urine Analysis, Portugal, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 30
Table 11: Clinical Chemistry, Portugal, Distribution Share by Revenue ($m), USD Constant, 2010-2011 31
Table 12: Clinical Chemistry, Portugal, Company Share by Revenue ($m), USD Constant, 2010-2011 33
Table 13: Genetic Testing, Portugal, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011 35
Table 14: Genetic Testing, Portugal, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018 37
Table 15: Genetic Testing, Portugal, Distribution Share by Revenue ($m), USD Constant, 2010-2011 38
Table 16: Genetic Testing, Portugal, Company Share by Revenue ($m), USD Constant, 2010-2011 40
Table 17: Haematology, Portugal, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011 42
Table 18: Haematology, Portugal, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018 44
Table 19: Haematology Reagents, Portugal, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 46
Table 20: Haematology Reagents, Portugal, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 48
Table 21: Immunohaematology, Portugal, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 50
Table 22: Immunohaematology, Portugal, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 52
Table 23: Haemostasis, Portugal, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 54
Table 24: Haemostasis, Portugal, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 56
Table 25: Haematology Rapid Tests, Portugal, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 58
Table 26: Haematology Rapid Tests, Portugal, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 60
Table 27: Haematology Cell Counters, Portugal, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 62
Table 28: Haematology Cell Counters, Portugal, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 64
Table 29: Haematology, Portugal, Distribution Share by Revenue ($m), USD Constant, 2010-2011 65
Table 30: Haematology, Portugal, Company Share by Revenue ($m), USD Constant, 2010-2011 67
Table 31: Histology And Cytology, Portugal, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011 69
Table 32: Histology And Cytology, Portugal, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018 71
Table 33: Histology And Cytology, Portugal, Distribution Share by Revenue ($m), USD Constant, 2010-2011 72
Table 34: Histology And Cytology, Portugal, Company Share by Revenue ($m), USD Constant, 2010-2011 74
Table 35: Immuno Chemistry, Portugal, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011 76
Table 36: Immuno Chemistry, Portugal, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018 78
Table 37: Disease Specific Immunochemistry, Portugal, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 80
Table 38: Disease Specific Immunochemistry, Portugal, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 82
Table 39: Drugs of Abuse / Toxicology, Portugal, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 84
Table 40: Drugs of Abuse / Toxicology, Portugal, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 85
Table 41: Endocrinology Tests, Portugal, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 87
Table 42: Endocrinology Tests, Portugal, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 89
Table 43: Immunochemistry Rapid Tests, Portugal, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 91
Table 44: Immunochemistry Rapid Tests, Portugal, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 93
Table 45: Therapeutic Drug Monitoring, Portugal, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 95
Table 46: Therapeutic Drug Monitoring, Portugal, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 97
Table 47: Immunochemistry Analyzers, Portugal, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 99
Table 48: Immunochemistry Analyzers, Portugal, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 101
Table 49: Immuno Chemistry, Portugal, Distribution Share by Revenue ($m), USD Constant, 2010-2011 102
Table 50: Immuno Chemistry, Portugal, Company Share by Revenue ($m), USD Constant, 2010-2011 104
Table 51: Infectious Immunology, Portugal, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011 106
Table 52: Infectious Immunology, Portugal, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018 108
Table 53: Infectious Immunology Rapid Tests, Portugal, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 110
Table 54: Infectious Immunology Rapid Tests, Portugal, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 112
Table 55: Infectious Immunology, Portugal, Distribution Share by Revenue ($m), USD Constant, 2010-2011 113
Table 56: Infectious Immunology, Portugal, Company Share by Revenue ($m), USD Constant, 2010-2011 115
Table 57: Microbiology Culture, Portugal, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011 117
Table 58: Microbiology Culture, Portugal, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018 119
Table 59: Microbiology Analyzers, Portugal, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 121
Table 60: Microbiology Analyzers, Portugal, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 123
Table 61: Microbiology Culture, Portugal, Distribution Share by Revenue ($m), USD Constant, 2010-2011 124
Table 62: Microbiology Culture, Portugal, Company Share by Revenue ($m), USD Constant, 2010-2011 126

1.2 List of Figures
Figure 1: In Vitro Diagnostics, Portugal, Overall Revenue ($m), USD Constant, 2004-2018 11
Figure 2: In Vitro Diagnostics, Portugal, Overall Revenue ($m), USD Constant, Historic, 2004-2011 13
Figure 3: In Vitro Diagnostics, Portugal, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 15
Figure 4: In Vitro Diagnostics, Portugal, Company Share (%), 2011 17
Figure 5: Clinical Chemistry, Portugal, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011 19
Figure 6: Clinical Chemistry, Portugal, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018 21
Figure 7: Clinical Chemisty Analyzers, Portugal, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 23
Figure 8: Clinical Chemisty Analyzers, Portugal, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 25
Figure 9: Urine Analysis, Portugal, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 27
Figure 10: Urine Analysis, Portugal, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 29
Figure 11: Clinical Chemistry, Portugal, Company Share (%), 2011 32
Figure 12: Genetic Testing, Portugal, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011 34
Figure 13: Genetic Testing, Portugal, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018 36
Figure 14: Genetic Testing, Portugal, Company Share (%), 2011 39
Figure 15: Haematology, Portugal, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011 41
Figure 16: Haematology, Portugal, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018 43
Figure 17: Haematology Reagents, Portugal, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 45
Figure 18: Haematology Reagents, Portugal, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 47
Figure 19: Immunohaematology, Portugal, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 49
Figure 20: Immunohaematology, Portugal, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 51
Figure 21: Haemostasis, Portugal, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 53
Figure 22: Haemostasis, Portugal, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 55
Figure 23: Haematology Rapid Tests, Portugal, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 57
Figure 24: Haematology Rapid Tests, Portugal, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 59
Figure 25: Haematology Cell Counters, Portugal, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 61
Figure 26: Haematology Cell Counters, Portugal, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 63
Figure 27: Haematology, Portugal, Company Share (%), 2011 66
Figure 28: Histology And Cytology, Portugal, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011 68
Figure 29: Histology And Cytology, Portugal, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018 70
Figure 30: Histology And Cytology, Portugal, Company Share (%), 2011 73
Figure 31: Immuno Chemistry, Portugal, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011 75
Figure 32: Immuno Chemistry, Portugal, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018 77
Figure 33: Disease Specific Immunochemistry, Portugal, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 79
Figure 34: Disease Specific Immunochemistry, Portugal, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 81
Figure 35: Drugs of Abuse / Toxicology, Portugal, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 83
Figure 36: Drugs of Abuse / Toxicology, Portugal, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 85
Figure 37: Endocrinology Tests, Portugal, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 86
Figure 38: Endocrinology Tests, Portugal, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 88
Figure 39: Immunochemistry Rapid Tests, Portugal, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 90
Figure 40: Immunochemistry Rapid Tests, Portugal, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 92
Figure 41: Therapeutic Drug Monitoring, Portugal, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 94
Figure 42: Therapeutic Drug Monitoring, Portugal, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 96
Figure 43: Immunochemistry Analyzers, Portugal, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 98
Figure 44: Immunochemistry Analyzers, Portugal, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 100
Figure 45: Immuno Chemistry, Portugal, Company Share (%), 2011 103
Figure 46: Infectious Immunology, Portugal, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011 105
Figure 47: Infectious Immunology, Portugal, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018 107
Figure 48: Infectious Immunology Rapid Tests, Portugal, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 109
Figure 49: Infectious Immunology Rapid Tests, Portugal, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 111
Figure 50: Infectious Immunology, Portugal, Company Share (%), 2011 114
Figure 51: Microbiology Culture, Portugal, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011 116
Figure 52: Microbiology Culture, Portugal, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018 118
Figure 53: Microbiology Analyzers, Portugal, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 120
Figure 54: Microbiology Analyzers, Portugal, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 122
Figure 55: Microbiology Culture, Portugal, Company Share (%), 2011 125
Figure 56: Global Markets Direct Methodology 138